IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q1 2016 Holdings

Filed 2016-04-21 | 16 holdings | $38.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Xenoport IncCOM98411C100$7.3K1,627,62819.1%
ELI Lilly & Co(LLY)COM532457108$4.7K65,40012.3%
Quest Diagnostics Inc(DGX)COM74834L100$4.5K63,59511.8%
Amicus Therapeutics Inc(FOLD)COM03152W109$2.8K333,5137.3%
Nevro Corp(NVROEUR)COM64157F103$2.8K49,3777.2%
Neurocrine Biosciences Inc(NBIX)COM64125C109$2.5K63,1886.5%
Unitedhealth Group Inc(UNH)COM91324P102$2.3K17,9006.0%
Teva Pharmaceutical(TEVA)ADR881624209$2.2K41,2865.8%
Impax Laboratories IncCOM45256B101$2.0K62,0505.2%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$1.7K140,5874.5%
Bio-Rad LabratoriesCOM90572207$1.6K12,0504.3%
Edwards Lifesciences Corp(EW)COM28176E108$1.4K15,7803.6%
Centene Corp(CNC)COM15135B101$73011,8501.9%
Quidel CorpCOM74838J101$71741,5501.9%
Orasure Technologies Inc(OSUR)COM68554V108$50069,2001.3%
Anacor Pharmaceuticals IncCOM032420101$4738,8501.2%